<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR206">
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Zeslawska</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Schweinitz</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Karcher</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Sondermann</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Sperl</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>St√ºrzebecher</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Jacob</surname>
    <given-names>U</given-names>
   </name>
  </person-group>
  <article-title>Crystals of the urokinase type plasminogen activator variant beta(c)-uPAin complex with small molecule inhibitors open the way towards structure-based drug design</article-title>
  <source>J Mol Biol</source>
  <year>2000</year>
  <volume>301</volume>
  <fpage>465</fpage>
  <lpage>475</lpage>
  <pub-id pub-id-type="doi">10.1006/jmbi.2000.3966</pub-id>
  <?supplied-pmid 10926521?>
  <pub-id pub-id-type="pmid">10926521</pub-id>
 </element-citation>
</ref>
